Long-term effect of fingolimod on cardiovascular functioning in people with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Haase, R. [1 ]
Forberger, C. [1 ]
Schilling, M. [1 ]
Piatkowski, F. [1 ]
Akgun, K. [1 ]
Rudiger, H. [1 ]
Ziemssen, T. [1 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Neurol, Ctr Clin Neurosci, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P726
引用
收藏
页码：609 / 610
页数：2
相关论文
共 50 条
  • [41] Long-term effect of natalizumab in a French cohort of patients with relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, Kevin
    Fabacher, Thibaut
    Collongues, Nicolas
    Kremer, Laurent
    Fleury, Marie-Celine
    Ongagna, Jean-Claude
    De Seze, Jerome
    NEUROLOGY, 2018, 90
  • [42] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Lublin, F. D.
    Dadon, Y.
    Gorfine, T.
    Davis, M. D.
    Sorensen, P. S.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 122 - 123
  • [43] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    Neurological Sciences, 2023, 44 : 2121 - 2129
  • [44] Drug holiday therapy of fingolimod in Japanese relapsing-remitting multiple sclerosis
    Ohtani, R.
    Masahiro, M.
    Akiyuki, U.
    Tomohiko, U.
    Hiroki, M.
    Satoshi, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 792 - 793
  • [45] Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
    Yavari, Fatemeh
    Oliazadeh, Pardis
    Radfar, Meisam
    Foroughipour, Mohsen
    Nikkhah, Karim
    Bakavoli, Alireza Heidari
    Saeidi, Morteza
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 233 - 242
  • [46] Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis
    Balássy, C
    Bernert, G
    Wöber-Bingöl, C
    Csapó, B
    Kornek, B
    Széles, J
    Fleischmann, D
    Prayer, D
    NEUROPEDIATRICS, 2001, 32 (01) : 28 - 37
  • [47] Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis
    Maggi, Gianpaolo
    Altieri, Manuela
    Risi, Mario
    Rippa, Valentina
    Borgo, Riccardo Maria
    Lavorgna, Luigi
    Bonavita, Simona
    Buonanno, Daniela
    D'Ambrosio, Alessandro
    Bisecco, Alvino
    Santangelo, Gabriella
    Tessitore, Alessandro
    Gallo, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 107 - 116
  • [48] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Ozakbas, Serkan
    Terzi, Murat
    Karabudak, Rana
    Sevim, Serhan
    Turkoglu, Recai
    Soysal, Aysun
    Balci, Belgin Petek
    Efendi, Husnu
    Turan, Omer Faruk
    Yuceyar, Nur
    Yetkin, Mehmet Fatih
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Guler, Sibel
    Agan, Kadriye
    Kiylioglu, Nefati
    Baba, Cavid
    Tuncer, Asli
    Koseoglu, Mesrure
    NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
  • [49] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [50] Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia
    Algahtani, Hussein
    Shirah, Bader
    Al Malik, Yaser
    Meftah, Ibraheem
    CLINICAL NEUROPHARMACOLOGY, 2020, 43 (02) : 35 - 38
12345